Stabilizing the glycosylation pattern of influenza B hemagglutinin following adaptation to growth in eggs

Vaccine

Volumn 26, Issue 3, 2008, Pages 361-371

  Chen, Zhongying ^a   Aspelund, Amy ^a   Jin, Hong ^a  

^a MEDIMMUNE   (United States)

Author keywords

Egg adaptation; Flumist ; HA antigenicity; HA glycosylation; Influenza B virus

Indexed keywords

ALPHA 2,3 LINKED SIALIC ACID RECEPTOR; ARGININE; HEMAGGLUTININ; INFLUENZA VACCINE; RECEPTOR; UNCLASSIFIED DRUG;

ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EGG; FERRET; GLYCOSYLATION; INFLUENZA; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS ATTACHMENT; VIRUS STRAIN;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CHICK EMBRYO; FERRETS; GLYCOSYLATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA B VIRUS; INFLUENZA VACCINES; MOLECULAR SEQUENCE DATA; REASSORTANT VIRUSES;

EID: 37549067406     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.013     Document Type: Article

References (42)

1. Wright P.F., and Webster R.G. Orthomyxoviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. 4rth ed. (2001), Lippincott Williams & Wilkins, Philadelphia 1533-1579
2. Rota P., Wallis T.R., Harmon M.W., Rota J.S., Kendal A.P., and Nerome K. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175 1 (1990) 59-68
3. Murphy B.R., and Coelingh K. Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol 15 2 (2002) 295-323
4. Robertson J.S. Clinical influenza virus and the embryonated Hen's egg. Rev Med Virol 3 2 (1993) 97-106
5. Robertson J.S., Bootman J.S., Newman R., Oxford J.S., Daniels R.S., Webster R.G., et al. Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virol 160 1 (1987) 31-37
6. Katz J.M., Naeve C.W., and Webster R.G. Host cell-mediated variation in H3N2 influenza viruses. Virology 156 (1987) 386-395
7. Gubareva L.V., Wood J.M., Meyer W.J., Katz J.M., Robertson J.S., Major D., et al. Codominant mixtures of viruses in reference strains of influenza virus due to host cell variation. Virology 199 1 (1994) 89-97
8. Katz J.M., and Webster R.G. Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs. J Infect Dis 160 2 (1989) 191-198
9. Wood J.M., Oxford J.S., Dunleavy U., Newman R.W., Major D., and Robertson J.S. Influenza A (H1N1) vaccine efficacy in animal models is influenced by two amino acid substitutions in the hemagglutinin molecule. Virology 171 1 (1989) 214-221
10. Kodihalli S., Justewicz D.M., Gubareva L.V., and Webster R.G. Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective. J Virol 69 8 (1995) 4888-4897
11. Meyer W.J., Wood J.M., Major D., Robertson J.S., Webster R.G., and Katz J.M. Influence of host cell-mediated variation on the international surveillance of influenza A (H3N2) viruses. Virology 196 1 (1993) 130-137
12. Robertson J.S., Naeve C.W., Webster R.G., Bootman J.S., Newman R., and Schild G.C. Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology 143 1 (1985) 166-174
13. Shaw M.W., Xu X., Li Y., Normand S., Ueki R.T., Kunimoto G.Y., et al. Reappearance and global spread of variants of influenza B/Victoria/2/87 lineage viruses in the 2000-2001 and 2001-2002 seasons. Virology 303 1 (2002) 1-8
14. Saito T., Nakaya Y., Suzuki T., Ito R., Saito T., Saito H., et al. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J Med Virol 74 2 (2004) 336-343
15. Hoffmann E., Mahmood K., Chen Z., Yang C., Spaete J., Greenberg H.B., et al. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. J Virol 79 17 (2005) 11014-11021
16. Bause E. Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes. Biochem J 209 2 (1983) 331-336
17. Gavel Y., and Von Heijne G. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng 3 5 (1990) 433-442
18. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., and Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 227 2 (1997) 493-499
19. Kumari KGS, Smith DF, Gulati U, Cummings RD, Air GM. Receptor binding specificity of recent human H3N2 influenza viruses. Virol J 2007;4:42.
20. Schulze I.T. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J Infect Dis 176 Suppl. 1 (1997) S24-S28
21. Reading P.C., Miller J.L., and Anders E.M. Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol 74 11 (2000) 5190-5197
22. Romanova J., Katinger D., Ferko B., Voglauer R., Mochalova L., Bovin N., et al. Distinct host range of influenza H3N2 virus isolates in Vero and MDCK cells is determined by cell specific glycosylation pattern. Virology 307 1 (2003) 90-97
23. Wagner R., Wolff T., Herwig A., Pleschka S., and Klenk H.D. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J Virol 74 14 (2000) 6316-6323
24. Wagner R., Heuer D., Wolff T., Herwig A., and Klenk H.D. N-Glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication. J Gen Virol 83 3 (2002) 601-609
25. Deshpande K.L., Fried V.A., Ando M., and Webster R.G. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc Natl Acad Sci USA 84 1 (1987) 36-40
26. Perdue M.L., Latimer J.W., Crawford J.M., Perdue M.L., Latimer J.W., and Crawford J.M. A novel carbohydrate addition site on the hemagglutinin protein of a highly pathogenic H7 subtype avian influenza virus. Virology 213 1 (1995) 276-281
27. Rudneva I.A., Ilyushina N.A., Timofeeva T.A., Webster R.G., and Kaverin N.V. Restoration of virulence of escape mutants of H5 and H9 influenza viruses by their readaptation to mice. J Gen Virol 86 10 (2005) 2831-2838
28. Mishin V.P., Novikov D., Hayden F.G., and Gubareva L.V. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors. J Virol 79 19 (2005) 12416-12424
29. Muyanga J., Matsuzaki Y., Sugawara K., Kimura K., Mizuta K., Ndumba I., et al. Antigenic and genetic analyses of influenza B viruses isolated in Lusaka, Zambia in 1999. Arch Virol 146 9 (2001) 1667-1679
30. Nakagawa N., Kubota R., Maeda A., and Okuno Y. Influenza B virus Victoria group with a new glycosylation site was epidemic in Japan in the 2002-2003 season. J Clin Microbiol 42 7 (2004) 3295-3297
31. Tung C.S., Goodman J.L., Lu H., and Macken C.A. Homology model of the structure of influenza B virus HA1. J Gen Virol 85 11 (2004) 3249-3259
32. Pechirra P., Nunes B., Coelho A., Ribeiro C., Goncalves P., Pedro S., et al. Molecular characterization of the HA gene of influenza type B viruses. J Med Virol 77 4 (2005) 541-549
33. Tsai H.P., Wang H.C., Kiang D., Huang S.W., Kuo P.H., Liu C.C., et al. Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005. J Clin Microbiol 44 8 (2006) 2705-2713
34. Zhang Y., Wen L.Y., Zhao X., Li Z., Guo J.F., Xu C.L., et al. Antigenic and genetic study of influenza virus B circulated in China in 2004-2005. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 20 2 (2006) 11-13
35. Alymova I.V., Kodihalli S., Govorkova E.A., Fanget B., Gerdil C., and Webster R.G. Immunogenicity and protective efficacy in mice of influenza B virus vaccines grown in mammalian cells or embryonated chicken eggs. J Virol 72 5 (1998) 4472-4477
36. Katz J.M., Wang M., and Webster R.G. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol 64 4 (1990) 1808-1811
37. Robertson J.S., Bootman J.S., Nicolson C., Major D., Robertson E.W., and Wood J.M. The hemagglutinin of influenza B virus present in clinical material is a single species identical to that of mammalian cell-grown virus. Virology 179 1 (1990) 35-40
38. Robertson J.S., Nicolson C., Bootman J.S., Major D., Robertson E.W., and Wood J.M. Sequence analysis of the haemagglutinin (HA) of influenza A (H1N1) viruses present in clinical material and comparison with the HA of laboratory-derived virus. J Gen Virol 72 11 (1991) 2671-2677
39. Oxford J.S., Newman R., Corcoran T., Bootman J., Major D., Yates P., et al. Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition. J Gen Virol 72 1 (1991) 185-189
40. Williams S.P., and Robertson J.S. Analysis of the restriction to the growth of nonegg-adapted human influenza virus in eggs. Virology 196 2 (1993) 660-665
41. Gambaryan A.S., Robertson J.S., and Matrosovich M.N. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology 258 2 (1999) 232-239
42. Mochalova L., Gambaryan A., Romanova J., Tuzikov A., Chinarev A., Katinger D., et al. Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs. Virology 313 2 (2003) 473-480